These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28209463)

  • 1. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
    Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
    J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
    Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
    Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
    Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
    J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus.
    Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
    PLoS One; 2014; 9(7):e101719. PubMed ID: 24988213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
    Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
    J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
    Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.
    Li XL; Li JJ; Guo YL; Zhu CG; Qing P; Wu NQ; Xu B; Gao RL
    Clin Cardiol; 2014 Sep; 37(9):558-65. PubMed ID: 25113039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
    Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
    J Diabetes Complications; 2015; 29(4):517-22. PubMed ID: 25736187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention.
    Deng Q; Hou J; Deng X; Zhong Z
    Perfusion; 2023 Mar; 38(2):393-400. PubMed ID: 35038275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
    Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
    Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
    Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
    Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
    Verdoia M; Barbieri L; Schaffer A; Cassetti E; Marino P; Bellomo G; Sinigaglia F; De Luca G;
    Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
    Huang ZS; Zheng ZD; Zhang JW; Tang LL; Zhou LL; Li SH; Xie XJ; Dong RM; Zhu JM; Liu JL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3981-3992. PubMed ID: 32329875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
    Verdoia M; Schaffer A; Barbieri L; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
    Atherosclerosis; 2014 Sep; 236(1):169-74. PubMed ID: 25055060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
    Zeng RX; Li JJ; Liao PD; Zhang MZ
    Int J Cardiol; 2016 Oct; 221():726-33. PubMed ID: 27428312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention.
    Liao J; Qiu M; Su X; Qi Z; Xu Y; Liu H; Xu K; Wang X; Li J; Li Y; Han Y
    Lipids Health Dis; 2024 Jun; 23(1):172. PubMed ID: 38849939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
    Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
    J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; De Luca G;
    Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.